• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Investment Round-up (February 2024)

By Femtech Insider Investment, Investment Round-ups, News March 4, 2024
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Acquisition, News, Pelvic Health, Women's Health April 12, 2021
Pelvalon’s Pelvic Health Therapy, Eclipse System, Is Now Covered by Medicate and Medicaid
Investor, News, Women's Health October 2, 2023
FemHealth Ventures Closes $32M Fund to Invest in Women’s Health
Recent Posts
  • Oura Adds Hormonal Birth Control Support and Menopause Insights; Partners with Twentyeight Health
  • Omaia Closes Pre-Seed Round for Pregnancy Emotional Support Platform
  • UNICEF Launches Femtech Ventures with First Cohort of 11 Startups Across Africa and Asia
  • Biotia Publishes Clinical Validation of AI-Powered UTI Test That Detects Pathogens Standard Cultures Miss
  • Carrot Partners with Origin to Bring Pelvic Floor Therapy Into Employer Benefits

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.